| Line 617: | Line 617: | ||
*[https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6946a4-H.pdf PDF Version] | *[https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6946a4-H.pdf PDF Version] | ||
*Citation: Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco Product Use Among Adults — United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69:1736–1742. DOI:10.15585/mmwr.mm6946a4 | *Citation: Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco Product Use Among Adults — United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69:1736–1742. DOI:10.15585/mmwr.mm6946a4 | ||
===2019: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876707/ E-Cigarettes and Smoking Cessation in Smokers With Chronic Conditions]=== | |||
*At a population level, e-cigarette use by smokers with chronic medical conditions is associated with more quitting activity and smoking abstinence. | |||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876707/pdf/nihms-1539531.pdf PDF Version] | |||
*Citation: Kalkhoran S, Chang Y, Rigotti NA. E-cigarettes and Smoking Cessation in Smokers With Chronic Conditions. Am J Prev Med. 2019;57(6):786-791. doi:10.1016/j.amepre.2019.08.017 | |||
*Acknowledgement: This study was supported by the National Heart, Lung, and Blood Institute of the NIH (K23HL136854 to Dr. Kalkhoran). | |||
edits